Online Program Home
My Program

Abstract Details

Activity Number: 672
Type: Invited
Date/Time: Thursday, August 4, 2016 : 10:30 AM to 12:20 PM
Sponsor: Pharmaceutical Research and Manufacturers of America
Abstract #318009 View Presentation
Title: Bayesian Approach to Design and Analysis of Composite Endpoints in Clinical Trials with Multiple Dependent Binary Outcomes
Author(s): Boris G. Zaslavsky*
Companies: FDA/CBER
Keywords: Bayesian analysis ; composite endpoints ; Dirichlet distribution ; hypotheses testing ; noninferiority
Abstract:

Testing hypotheses with multiple primary endpoints may require unmanageably large populations. Composite endpoints consisting of several binary events may be used to reduce a trial to a manageable size. The primary difficulties with composite endpoints are that different endpoints may have different clinical importance and that higher-frequency variables may overwhelm effects of smaller, but equally important, primary outcomes. To compensate for these inconsistencies, each type of event is weighted, and the total number of weighted events is counted. To reflect the mutual dependency of primary endpoints and to make the weighting method effective in small clinical trials, we use the Bayesian approach. We assume a multinomial distribution of multiple endpoints with Dirichlet priors and apply the Bayesian test of noninferiority to the calculation of weighting parameters. We use composite endpoints to test hypotheses of superiority in single-arm and two-arm clinical trials. The composite endpoints have a beta distribution. We illustrate this technique with an example. The results provide a statistical procedure for creating composite endpoints from multiple clinically important endpoin


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association